Skip to main content
Top

04-09-2024 | Acute Coronary Syndrome | News

ESC 2024

HbA1c screening in ACS puts de novo (pre)diabetes in good focus

MedNet.nl: Elevated HbA1c was seen in more than 35% of patients treated for acute coronary syndrome with percutaneous coronary intervention, who were not previously diagnosed with diabetes. Diabetes significantly increases the risk of serious adverse cardiac and cerebrovascular events in these individuals. Active diabetes screening and treatment are therefore extremely important for these patients.

Related topics

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

Keynote webinar | Spotlight on medication adherence

  • Webinar | 27-06-2024 | 18:00 (CEST)

Medication non-adherence is a major barrier to effective healthcare delivery; half of all patients do not follow their doctor’s recommendations or treatment plan.

Our experts explain the fundamentals with a practical discussion of how to manage non-adherence in two common scenarios: hypertension and asthma control.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Watch now